Two important contributors of early protection are speed of replication and onset of immunity, according to Alberto Giner, ...

Vaccines Tobacco Hepatitis B virus surface antigen (HBsAg ... into fertilized fish eggs results in 6.2% retention of the vector at one year of age, as well as significantly increased growth ...

New vaccine technologies, such as viral vector and nucleic acid-based vaccines ... can be produced using recombinant technology in systems like yeast, bacteria, or cell cultures.

AstraZeneca has joined with Oxford University to develop and distribute the institution’s potential coronavirus vaccine ... ChAdOx1 nCoV-19 uses a viral vector based on a weakened version ...

Laboratory of Advanced Biotechnology, Beijing Institute of Biotechnology, Beijing, China Introduction: Adenovirus (Ad) vectors are widely used for gene delivery, and some of them have been approved ...

For many years, the potential of immunoglobulin M (IgM) antibodies was not fully understood because of characteristics different to the well-known immunoglobulin G type like low target affinity, cross ...

We used a recently described HBV-persistent mouse model based on a recombinant adenovirus-associated virus encoding an over length genome ... based on a non-replicative adenovirus 5 vector encoding a ...

Scientists have pioneered an influenza virus vector-based nasal spray vaccine platform and developed a nasal spray H5N1 avian influenza vaccine. During the early COVID-19 pandemic, this platform ...

The combination of synchronous experimental process development and digital twin core model development is among the first of its kind.

The global vaccine CDMO market is set to witness a growth rate of 8% in the next 5 years. Increasing demand for vaccines, ...